Blog

A 63-year-old man with a 40-pack-year smoking history and known chronic obstructive pulmonary disease (COPD) returns for routine follow-up. Over the past 12 months, he has had 3 exacerbations—each treated with systemic corticosteroids and antibiotics; 2 required a brief hospital admission. He now complains of increased dyspnea on minimal exertion (modified Medical Research Council Dyspnea Scale [mMRC] grade 3) and reports a chronic productive cough. Which of the following in this patient’s history is known to be the strongest predictor of future exacerbation risk?

A patient is prescribed Pantaprozole for the management of GERD. Which of the following best describes the mechanism by which this medication promotes relief?

Which of the following is considered a nonpharmacological assessment of safety for a patient newly diagnosed with dementia?

Which of the following is an Extrapyramidal Symptom (EPS) commonly associated with first-generation antipsychotics?

Dual therapy with an ACE inhibitor and an ARB is recommended for maximum kidney protection in CKD.

What is the mechanism of action for Thiazide diuretics?

To achieve a “steady state” and maximum acid suppression, how long must a patient typically take a PPI?

When treating a patient with Donepezil, which class of cardiac medications should be used with caution because they can also prolong the PR interval?

Which medication blocks muscarinic cholinergic receptors to reduce vagal tone and cause bronchodilation?

A patient was recently diagnosed with a stroke, and as a preventive measure for future stroke, she was placed on Warfarin. What should be the therapeutic range of INR when the patient is on Warfarin?